Q FEVER, DIAGNOSIS AND MANAGEMENT

VA Pharmacy Benefits Management Services, Medical Advisory Panel, VISN Pharmacist Executives, and Office of Public Health ... one subject experienced SAEs considered related to dolutegravir which was a case of drug eruption with elevated ALT and hyperbilirubinemia. In the 60-day Safety Update Report, one subject had a suicide attempt that was ... ................
................